Higher rates of metabolic syndrome among women taking zidovudine as compared to tenofovir in rural Africa: preliminary data from the CART-1 study

INTRODUCTION: Due to its side effects stavudine (D4T) has been replaced by zidovudine (AZT) and tenofovir (TDF) in most low- and middle-income countries (LMICs). In 2014 about 38% of adult first-line regimens contain AZT and 62% TDF [1]. Whereas the unfavourable metabolic outcomes of D4T in comparis...

Descripción completa

Detalles Bibliográficos
Autores principales: Labhardt, Niklaus Daniel, Cheleboi, Molisana, Faturyiele, Olatunbosun, Motlatsi, Mokete M, Pfeiffer, Karolin, Ismael Lejone, Thabo, Cerutti, Bernard, Muser, Jürgen, Shankar Gupta, Ravi, Lynen, Lutgarde, Hatz, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224833/
https://www.ncbi.nlm.nih.gov/pubmed/25394059
http://dx.doi.org/10.7448/IAS.17.4.19552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224833/
https://www.ncbi.nlm.nih.gov/pubmed/25394059
http://dx.doi.org/10.7448/IAS.17.4.19552

Ejemplares similares